Skip to main content

Table 3 The somatic mtDNA mutations and clinicopathological characteristics of esophageal tumors.

From: Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer

Case Sex Age (Yrs) Tumor Size (cm3) TNM Survival Stage mtDNA tu/nl Ratio Number of Mutation Mutation
E01 M 42 24.75 T3N1M0 Alive, 51 month post surgery III 0.67 0  
E02 F 57 8.6 T3N0M0 Alive, 48 month post surgery IIA 1.56 1 T310C, 303→ 315 ins C
E03 M 46 12 T2N1M0 10 month IIB 0.71 0  
E04 M 65 0.2 T1N0M0 Alive, 48 month post surgery I 2.7 0  
E05 M 50 19.5 T3N1M0 4 month III 0.25 2 303–309 del C (C8→ C7/8), A1544T
E06 M 70 0.65 T2N0M0 Alive, 4 month IIA 1.6 0  
E07 M 52 36 T3N0M0 13 month IIA 1.8 0  
E08 M 62 18 T4N0M0 12 month III 1.6 0  
E09 M 66 12 T3N1M0 12 month III 0.8 1 303–309 del C (C9/8→ C8/9)
E10 M 73 9 T3N1M0 6 month III 2.0 1 303–309 ins C (C8→ C8/9)
E11 M 68 10 T2N1M0 34 month IIB 1.8 0  
E12 M 51 2.55 T1N0M0 Alive, 60 month post surgery I 3.1 1 G10500A
E13 M 52 2 T1N0M0 3 month I 1.5 0  
E14 M 60 11.25 T3N1M0 7 month III 1.4 2 303–309 ins CC(C7→ C9/10), G9377A
E15 M 67 26.4 T3N1M0 5 month III 0.75 2 303–309 del C, A9182G
E16 M 68 0.06 T2N0M0 Alive, 38 month post surgery IIA 0.48 1 303–309 ins C (C7/8→ C7/8/9)
E17 M 61 24.75 T2N1M0 20 month IIB 3.1 1 303–309 ins C (C8→ C9)
E18 M 38 20 T4N1M0 12 month III 0.35 1 10941del TAACAACCCCC
E19 M 68 36 T2N1M0 14 month IIB 0.7 1 303–309 del CC (C9/10→ C7)
E20 M 61 39 T3N1M0 8 month III 0.7 0  
  1. TNM: tumor-node-metastasis classification